Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.
Elisabeth Coart, PhD
Advertisement
Articles by Elisabeth Coart, PhD
Applied Clinical Trials
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology.
Advertisement
Latest Updated Articles
- Integration of Biomarker Validation in Oncology Trials
August 13th 2020
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
2
Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease
3
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
4
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
5